pegfilgrastim · Medicine question

Which malignancies are excluded from pegfilgrastim's indication for reducing chemotherapy-associated neutropenia?

Name: Which malignancies are excluded from pegfilgrastim's indication for reducing chemotherapy-associated neutropenia?
Published: 2026-11-08T14:29:32.964Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Pelmeg (pegfilgrastim)'s indication for reducing neutropenia duration and febrile neutropenia incidence in adults receiving cytotoxic chemotherapy excludes chronic myeloid leukaemia and myelodysplastic syndromes.

Sources for this answer

Pelmeg 6 mg solution for injection in pre-filled syringeNapp Pharmaceuticals Limited · emc · SmPC §4.1 Therapeutic Indications · Version 8Document updated 3 March 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about pegfilgrastim